IONS· Ionis Pharmaceuticals Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 6 quarters
IONS Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$12.5B
Enterprise value$13.1B
EV / EBITDA (TTM)-38.81
P/E ratio (TTM)—
Forward P/E-122.13
P/S ratio11.82
P/B ratio25.56
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$911M
Free cash flow (TTM)-$808M
Total cash$2.0B
Total debt$2.6B
Debt / equity531.05
Current ratio4.10
Income Statement
Total revenue (TTM)$1.1B
Revenue per share (TTM)6.55
Gross profit (TTM)$116M
EBITDA (TTM)-$339M
Net income (TTM)-$327M
EPS diluted (TTM)-2.01
Shares outstanding165,262,556
Float shares163,980,119
Profitability
Gross margin10.94%
Operating margin-47.72%
EBITDA margin-32.00%
Net margin-30.90%
Efficiency
Return on assets (TTM)-7.03%
Return on equity (TTM)-67.62%
Price History
Current price$75.71
52 Week high$86.74
52 Week low$32.00
50 day average$74.60
200 day average$70.54
Average volume (10 day)2,051,630
1-year beta0.38
1-year price target$100.74
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:38 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com